Literature DB >> 16864748

Controversial treatment of atherosclerotic renal vascular disease: the cardiovascular outcomes in renal atherosclerotic lesions trial.

Lance D Dworkin1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16864748     DOI： 10.1161/01.HYP.0000233513.19720.b7

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

1.  Atherosclerosis renal artery stenosis and in-stent restenosis in a diabetic patient: Targeting on diabetic dyslipidemia is a key intervention.

Authors:  M Maranghi; F Pugliese; R Cianci; M Colotto; C Durante; M G Anatra; P Coletta; S Mercuri; M Rossetti; S Morano; S Filetti
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

2.  Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.

Authors:  Silvia Kelsen; John E Hall; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-06

3.  Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.

Authors:  George S Chrysant; Mark C Bates; Timothy M Sullivan; William B Bachinsky; Jeffrey J Popma; Lei Peng; Hend L Omran; Michael R Jaff
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-07       Impact factor: 3.738

4.  Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.

Authors:  Alejandro R Chade; Nicholas J Stewart; Patrick R Peavy
Journal:  Kidney Int       Date:  2013-12-18       Impact factor: 10.612

5.  Angiotensin receptor blockade has protective effects on the poststenotic porcine kidney.

Authors:  Xin Zhang; Alfonso Eirin; Zi-Lun Li; John A Crane; James D Krier; Behzad Ebrahimi; Aditya S Pawar; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

Review 6.  Diagnosis and management of renovascular disease and renovascular hypertension.

Authors:  Michael J Bloch; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.